This template is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.
In the interest of uniformity, please correct all N-benzyl compound naming to the established '25X-NBXXX' nomenclature. — Preceding unsigned comment added by 220.127.116.11 (talk) 19:57, 10 January 2014 (UTC)
Only muscimol and gaboxadol are true GABA-A-Agonists, i.e. bind to the same site of the receptor as GABA itself. The pharmacology of ibotenic acid beside of being a prodrug to muscimol is quite unknown, as far as I know. The "Z-drugs" (es)zopliclone, zolpidem and zaleplon, on the other hand, are not direct agonists, but positive allosteric modulators, just as the benzodiazepines, which allosteric binding site on the GABA-A-receptor they also share. Since this different pharmacological actions lead to huge differences in the subjective effects of those drugs, I really don't think that they should be lumped together. --Diogenes2000 (talk) 17:01, 16 November 2014 (UTC)